autoimmune disease

closed shuttered shut down closed
Biotech

Octagon shuts down after R&D challenges put it behind the 8 ball

The Novo Nordisk-allied autoimmune disease biotech is winding down after deprioritizing its lead asset and running into unresolved biology questions.
Nick Paul Taylor Apr 29, 2025 7:40am
GPS navigation to pins and multiple markers on route

Genentech builds autoimmune Repertoire with $765M deal

Apr 23, 2025 7:00am
Reorganization team change restructure

Immunovant narrows R&D focus as Roivant execs join C-suite

Apr 21, 2025 10:00am
Three blocks displaying from left to right a person a handshake and another person

Boehringer lines up B-cell depletion autoimmune R&D via Cue deal

Apr 15, 2025 4:45am
A photo finish at a horse race with both horses crossing the finish line

J&J links FcRn blocker to sustained benefits as FDA ruling nears

Apr 8, 2025 10:21am
crash fall stock shares market economy down red arrow

Rallybio drops lead program as phase 2 data disappoint

Apr 8, 2025 8:52am